Skip to main content

Supplementary Figure S6 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma

Publication ,  Other
Chaudhary, R; Slebos, RJC; Noel, LC; Song, F; Poole, MI; Hoening, DS; Hernandez-Prera, JC; Conejo-Garcia, JR; Guevara-Patino, JA; Wang, X ...
May 22, 2023

<p>TIMEx scores for the Immune gene signature among the 15 patients classified into the Hypoxia, Mixture and Immune subgroups.</p>

Duke Scholars

DOI

Publication Date

May 22, 2023
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chaudhary, R., Slebos, R. J. C., Noel, L. C., Song, F., Poole, M. I., Hoening, D. S., … Chung, C. H. (2023). Supplementary Figure S6 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma. https://doi.org/10.1158/2767-9764.23057200.v1
Chaudhary, Ritu, Robbert J. C. Slebos, Leenil C. Noel, Feifei Song, Maria I. Poole, Dirk S. Hoening, Juan C. Hernandez-Prera, et al. “Supplementary Figure S6 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma,” May 22, 2023. https://doi.org/10.1158/2767-9764.23057200.v1.
Chaudhary R, Slebos RJC, Noel LC, Song F, Poole MI, Hoening DS, Hernandez-Prera JC, Conejo-Garcia JR, Guevara-Patino JA, Wang X, Xie M, Tan AC, Chung CH. Supplementary Figure S6 from EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma. 2023.

DOI

Publication Date

May 22, 2023